Source link : https://www.newshealth.biz/health-news/sglt-2-inhibitors-reduce-dementia-risk-vs-dpp-4-inhibitors/
Patients with type 2 diabetes treated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a significantly lower risk of developing dementia and Alzheimer’s disease than those receiving dipeptidyl peptidase-4 (DPP-4) inhibitors, with the benefits appearing to increase over time, findings from a large population-based study showed. “SGLT-2 inhibitors might prevent dementia, providing greater benefits with longer treatment,” […]
Author : News Health
Publish date : 2024-09-13 11:24:09
Copyright for syndicated content belongs to the linked Source.
Categories